Skip to content

Study · Measured the body's own peptide · 1998

2 results

Epithelial-mesenchymal cell interactions and participation of the neuroendocrine markers in tumor development. Immunohistochemical study.

Zółtowska A, Stepiński J, Kuczkowski J, Kamiński M, Cynowska B, Kruszewski W

Archivum immunologiae et therapiae experimentalis1 Jan 1998

PMID9779291 (opens in a new tab)PepBankPUB-09779291
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Natural levels measured2

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In non-small cell lung carcinomas, epithelial pearls showed the body's own thymosin alpha‑1 by immunohistochemistry.

    In plain wordsIn lung tumour tissue, the body's own thymosin alpha‑1 was found in structures called epithelial pearls.

    Peptide
    Thymosin alpha-1
    Outcome
    Not applicableThymosin alpha 1 in epithelial pearls of lung carcinomas
    Study

    n: not reported in source

    Human tumor tissue, immunohistochemistry
    Outcome group
    Endogenous peptide levels · Cancer

    Source sentences

    Summary
    The epithelial pearls especially abundant in non-small cell lung carcinomas demonstrated immunohistochemical analogy to Hassall's bodies: they had monocytogenic cell inside and they displayed thymosin alpha 1 (TA1), as well as mucin secretion and minute calcification.
    1 context sentence
    Summary · context
    Similar results have been observed in the cancers of lung, salivary gland and colon, investigated in the current study.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

  2. 02HumanEndogenous levelObservational studyOther

    All investigated cancer types showed the body's own thymosin alpha‑1 by immunohistochemistry.

    In plain wordsIn all cancer tissues studied, the body's own thymosin alpha‑1 was detected.

    Peptide
    Thymosin alpha-1
    Outcome
    Not applicableThymosin alpha 1 in investigated cancers
    Study

    n: not reported in source

    Human tumor tissue, immunohistochemistry
    Outcome group
    Endogenous peptide levels · Cancer

    Source sentences

    Summary
    All types of investigated cancers demonstrated TA1.
    1 context sentence
    Summary · context
    Similar results have been observed in the cancers of lung, salivary gland and colon, investigated in the current study.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.